title: US FDA feels the heat from Congressional hearings.
authors.forename: Samuel
authors.initials: S
authors.lastname: Loewenberg
mesh_terms: D017277:Drug Approval / Q000191:economics* / Q000379:methods; D004340:Drug Contamination; D004345:Drug Industry / Q000592:standards*; D008119:Lobbying; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics* / Q000592:standards